Primary Biliary Cholangitis Trial, Not Yet Recruiting (NCT07319169)

Primary Biliary Cholangitis Trial, Not Yet Recruiting NCT07319169 Sponsor: Universitair Ziekenhuis Brussel Condition: Primary Biliary Cholangitis

Printed from Voxsanity (voxsanity.com.au) — NCT07319169 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Primary Biliary Cholangitis

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are 18 years old or older
You are seen as an outpatient (not staying overnight in hospital) at UZ Brussels
You have been diagnosed with Primary Biliary Cholangitis (PBC), confirmed by specific blood tests and/or a liver biopsy
You are currently being treated with ursodeoxycholic acid and/or bezafibrate (medications commonly used for this liver condition)

Who may not be able to join:

You are under 18 years old
You have a medical condition that makes a specific liver scan called a FibroScan unsafe for you, such as fluid build-up in the abdomen (ascites) or severe heart failure (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +32 2 477 60 11

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07319169

Sponsor: Universitair Ziekenhuis Brussel

Phase: Not Applicable

Status: Not Yet Recruiting

Condition: Primary Biliary Cholangitis

Trial contact: +32 2 477 60 11

More information: https://clinicaltrials.gov/study/NCT07319169

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are 18 years old or older
You are seen as an outpatient (not staying overnight in hospital) at UZ Brussels
You have been diagnosed with Primary Biliary Cholangitis (PBC), confirmed by specific blood tests and/or a liver biopsy
You are currently being treated with ursodeoxycholic acid and/or bezafibrate (medications commonly used for this liver condition)

Who may not be able to join:

You are under 18 years old
You have a medical condition that makes a specific liver scan called a FibroScan unsafe for you, such as fluid build-up in the abdomen (ascites) or severe heart failure (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Not Yet Recruiting

Phase

Not Applicable

Sponsor

Universitair Ziekenhuis Brussel

Registry

ClinicalTrials.gov

Start date

1 July 2026

Est. completion

1 January 2028

Where this trial is recruiting

🇧🇪 Belgium

Primary endpoints

Correlation between spleen stiffness measurement and biochemical assessment of severity of PBC.; Correlation between spleen stiffness measurement and clinical signs of portal hypertension, liver related events and PH-related bleeding; Correlation between spleen stiffness measurement and endoscopic signs of portal hypertension, liver related events and PH-related bleeding; Correlation between spleen stiffness measurement and quality of life assessment of severity of PBC.; Evaluation of the evolution of liver or spleen stiffness on treatment of PBC

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov